Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers

Cancer Research

Volumn 64, Issue 1, 2004, Pages 64-71

  Wang, Zhigang C ^a   Lin, Ming ^c   Wei, Lee Jen ^c   Li, Cheng ^b,c   Miron, Alexander ^a   Lodeiro, Gabriella ^a   Harris, Lyndsay ^a,b   Ramaswamy, Sridhar ^a,d   Tanenbaum, David M ^a   Meyerson, Matthew ^a   Iglehart, James D ^a,b   Richardson, Andrea ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROTEIN P53; RNA;

ARTICLE; BREAST CANCER; CHROMOSOME; CONTROLLED STUDY; GENE; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 5; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

APPLICATION DOMAINS; AUTHENTICATION; BULLETIN-BOARD SYSTEMS; PEER-TO-PEER SYSTEMS;

ALGORITHMS; COMPUTER SOFTWARE; DISTRIBUTED COMPUTER SYSTEMS; FAULT TOLERANT COMPUTER SYSTEMS; SECURITY OF DATA; SYNCHRONIZATION; TELECOMMUNICATION SERVICES; TOPOLOGY;

COMPUTER NETWORKS;

EID: 13244252382     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2570     Document Type: Article

References (42)

1. Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
2. Courjal, F., and Theillet, C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res., 57: 4368-4377, 1997.
3. Vogelstein, B., Fearon, E. R., Kem, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Wash. DC), 244: 207-211, 1989.
4. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., and White, R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784, 1983.
5. Smith, S. A., Easton, D. F., Evans, D. G., and Ponder, B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2: 128-131, 1992.
6. Nigro, J, M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
7. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
8. Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W., Daly, P. A., Ford, D., Easton, D. F., and Stratton, M. R. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 10: 1673-1675, 1995.
9. Welcsh, P. L., and King, M. C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet., 10: 705-713, 2001.
10. Shen, C. Y., Yu, J. C., Lo, Y. L., Kuo, C. H., Yue, C. T., Jou, Y. S., Huang, C. S., Lung, J. C., and Wu, C. W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res., 60: 3884-3892, 2000.
11. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Bimbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
12. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. Molecular portraits of human breast tumours. Nature (Lond.), 406: 747-752, 2000.
13. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M.,.Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98: 10869-10874, 2001.
14. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bitme, r M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O. P., Wilfond, B., Borg, A., and Trent, J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
15. Mei, R., Galipeau, P. C., Prass, C., Berno, A., Ghandour, G., Patil, N., Wolff, R. K., Chee, M. S., Reid, B. J., and Lockhart, D. J. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res., 10: 1126-1137, 2000.
16. Lindblad-Toh, K., Tanenbaum, D. M., Daly, M. J., Winchester, E., Lui, W. O., Villapakkam, A., Stanton, S. E., Larsson, C., Hudson, T. J., Johnson, B. E., Lander, E. S., and Meyerson, M. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat. Biotechnol., 18: 1001-1005, 2000.
17. Hoque, M. O., Lee, C. C., Cairns, P., Schoenberg, M., and Sidransky, D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res., 63: 2216-2222, 2003.
18. Dumur, C. I., Dechsukhum, C., Ware, J. L., Cofield, S. S., Best, A. M., Wilkinson, D. S., Garrett, C. T., and Ferreira-Gonzalez, A. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics, 81: 260-269, 2003.
19. Lieberfarb, M., Lin, M., Lechpammer, M., Li, C., Tanenbaum, D, M., Wright, R., Shim, J., Kantoff, P. W., Loda, M., Meyerson, M., and Sellers, W. R. Genome-wide loss-of-heterozygosity analysis from laser-capture microdissected prostate cancer using SNP arrays and a novel bioinformatics platform dChipSNP. Cancer Res., (in press)
20. Schubert, E. L., Hsu, L., Cousens, L. A., Glogovac, J., Self, S., Reid, B. J., Rabinovitch, P. S., and Porter, P. L. Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am. J. Pathol., 160: 73-79, 2002.
21. Signoretti, S., Di Marcotullio, L., Richardson, A., Ramaswamy, S., Isaac, B., Rue, M., Monti, F., Loda, M., and Pagano, M. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J. Clin. Investig., 110: 633-641, 2002.
22. Lin, M., Wei, L-J., Sellers, W., Lieberfarb, M., Wong, W. H., and Li, C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics, in press, 2003.
23. Nathanson, K. L., Shugart, Y. Y., Omaruddin, R., Szabo, C., Goldgar, D., Rebbeck, T. R., and Weber, B. L. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Hum. Mol. Genet., 11: 1327-1332, 2002.
24. Osborne, R. J., and Hamshere, M. G. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res., 60: 3706-3712, 2000.
25. Korsching, E., Packeisen, J., Agelopoulos, K., Eisenacher, M., Voss, R., Isola, J., van Diest, P. J., Brandt, B., Boecker, W., and Buerger, H. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab. Investig., 82: 1525-1533, 2002.
26. Orsetti, B., Courjal, F., Cuny, M., Rodriquez, C., and Theillet, C. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. Oncogene, 18: 6262-6270, 1999.
27. Roylane, R., Gorman, P., Harris, W., Liebmann, R., Barnes, D., Hanby, A., and Sheer, D. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res., 59: 1433-1436, 1999.
28. Emi, M., Yoshimoto, M., Sato, T., Matsumoto, S., Utada, Y., Ito, I., Minobe, K., Iwase, T., Katagiri, T., Bando, K., Akiyama, F., Harada, Y., Fukino, K., Sakamoto, G., Matsushima, M., Iida, A., Tada, T., Saito, H., Miki, Y., Kasumi, F., and Nakamura, Y. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer. Genes Chromosomes Cancer, 26: 134-141, 1999.
29. Jones, C., Merrett, S., Thomas, V. A., Barker, T. H., and Lakhani, S. R. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J. Pathol., 199: 152-156, 2003.
30. el-Rifai, W., Tarmo, L., Hemmer, S., Forsti, A., Pedersen, N., Lichtenstein, P., Ahlbom, A., Soderberg, M., Knuutila, S., and Hemminki, K. DNA copy number losses at 1p32-pter in monozygotic twins concordant for breast cancer. Cancer Genet. Cytogenet., 112: 169-172, 1999.
31. Kremmidiotis, G., Baker, E., Crawford, J., Eyre, H. J., Nahmias, J., and Callen, D. F. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics, 49: 467-471, 1998.
32. Jones, C., Foschini, M. P., Chaggar, R., Lu, Y. J., Wells, D., Shipley, J. M., Eusebi, V., and Lakhani, S. R. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab. Investig., 80: 831-836, 2000.
33. Jones, C., Nonni, A. V., Fulford, L., Merrett, S., Chaggar, R., Eusebi, V., and Lakhani, S. R. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br. J. Cancer, 85: 422-427, 2001.
34. Davidoff, A. M., Humphrey, P. A., Iglehart, J. D., and Marks, J. R. Genetic basis for p53 overexpression in human breast cancer. Proc. Natl. Acad. Sci. USA, 88: 5006-5010, 1991.
35. Jain, A. N., Chin, K., Borresen-Dale, A-L., Erikstein, B. K., Lonning, P. E., Kaaresen, R., and Gray, J. W. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl. Acad. Sci. USA, 98: 7952-7957, 2001.
36. Johannsson, O. T., Idvall, I., Anderson, C., Borg, A., Barkardottir, R. B., Egilsson, V., and Olsson, H. Tumor biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
37. Tirkkonen, M., Johannsson, O., Agnarsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O. P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
38. Krop, I., Maguire, P., Lahti-Domenici, J., Lodeiro, G., Richardson, A., Johannsdottir, H. K., Nevanlinna, H., Borg, A., Gelman, R., Barkardottir, R. B., Lindblom, A., and Polyak, K. Lack of HIN-1 methylation in BRCA1 linked and "BRCA1-like" breast tumors. Cancer Res., 63: 2024-2027, 2003.
39. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Lori, T., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Wash. DC), 266: 120-122, 1994.
40. Wang, X., Zou, L., Zheng, H., Wei, Q., Elledge, S. J., and Li, L. Genomic instability and endoreduplication triggered by RAD 17 deletion. Genes Dev., 17: 965-970, 2003.
41. Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Homer, J., DePinho, R. A., and Alt, F. W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (Lond.), 404: 897-900, 2000.
42. Jallepalli, P. V., Waizenegger, I. C., Bunz, F., Langer, S., Speicher, M. R., Peters, J. M., Kinzler, K. W., Vogelstein, B., and Lengauer, C. Securin is required for chromosomal stability in human cells. Cell, 105: 445-457, 2001.